After Fidiji Simo, OpenAI researcher Miles Wang is leaving the company to focus on …
OpenAI researcher Miles Wang is reportedly leaving to start a new AI drug discovery company. This new venture is expected to raise significant funding from investors. The startup aims to find new uses for existing medicines and revive failed drugs. Several other OpenAI researchers are also anticipated to join Wang's new company. This move highlights growing investor interest in AI-powered pharmaceutical innovation.
OpenAI researcher Miles Wang is reportedly leaving to start a new AI drug discovery company. This new venture is expected to raise significant funding from investors. The startup aims to find new uses for existing medicines and revive failed drugs. Several other OpenAI researchers are also anticipated to join Wang's new company. This move highlights growing investor interest in AI-powered pharmaceutical innovation.
